Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phase I clinical study for recombinant human granulocyte colony-stimulating factor.

S Asano1, N Shirafuji, K Watari

  • 1Department of Pathological Pharmacology, University of Tokyo, Japan.

Behring Institute Mitteilungen
|August 1, 1988
PubMed
Summary

Recombinant human granulocyte colony-stimulating factor (rh G-CSF) effectively increases neutrophil counts in healthy adults. Repeated dosing showed no accumulation but suggested bone marrow stimulation, impacting neutrophil release and precursor cell levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum erythropoietin titers in hematological malignancies and related diseases.

International journal of cell cloning·1992
Same author

Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

Experimental hematology·1992
Same author

Production of interleukin 3 and granulocyte-macrophage colony-stimulating factor from stimulated blood mononuclear cells in patients with aplastic anemia.

Experimental hematology·1992
Same author

Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus.

Annals of the rheumatic diseases·1992
Same author

Changes of enzyme activity levels in red blood cells in hemodialysis patients by recombinant human erythropoietin.

Nihon Jinzo Gakkai shi·1992
Same author

[Present status and future aspects of clinical use of cytokines].

Nihon rinsho. Japanese journal of clinical medicine·1992

Area of Science:

  • Pharmacology
  • Hematology
  • Biotechnology

Background:

  • Recombinant human granulocyte colony-stimulating factor (rh G-CSF) is crucial for neutrophil production.
  • Understanding its pharmacokinetics, safety, and efficacy in healthy adults is essential for therapeutic applications.

Purpose of the Study:

  • To evaluate the pharmacokinetics, safety, and efficacy of purified rh G-CSF derived from Chinese hamster ovary (CHO) cells.
  • To assess the dose-dependent effects of rh G-CSF on neutrophil counts and function.

Main Methods:

  • Single subcutaneous administration of rh G-CSF to healthy adults.
  • Monitoring of serum G-CSF levels, blood cell counts, and neutrophil function (chemiluminescence).
  • Analysis of bone marrow cell populations (M/E ratio, precursor cells) after repeated dosing.

Related Experiment Videos

Main Results:

  • Serum G-CSF levels increased dose-dependently post-injection (C-max ~140 pg/mL, T-max 4h, T-half 5h at 10 µg/mL).
  • Transient, dose-proportional neutrophilia occurred without affecting other blood cell counts.
  • Repeated daily injections (10 µg/day for 7 days) induced neutrophilia without serum accumulation, but neutrophil function and peak counts decreased over time, with increased M/E ratio and precursor cells in bone marrow.

Conclusions:

  • Purified rh G-CSF (CHO-derived) demonstrates predictable pharmacokinetics and induces neutrophilia in healthy adults.
  • While safe in single doses, repeated administration suggests a potential impact on bone marrow's neutrophil release capacity and stimulates myeloid precursors.